Showing results (271-280 of 429) with videos related to
Sort By:
Pageof 43
Cell|July 9, 2019
VEGAS as a Platform for Facile Directed Evolution in Mammalian CellsJustin G English, Reid H J Olsen, Katherine Lansu, et al.The Journal of Pharmacology and Experimental Therapeutics|October 17, 2014
The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivoKate L White, J Elliott Robinson, Hu Zhu, et al.Plos Biology|November 22, 2013
In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feedingGeorge A Lemieux, Michael J Keiser, Maria F Sassano, et al.Neuropharmacology|August 16, 2017
Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplaceMichael H Baumann, Susruta Majumdar, Valerie Le Rouzic, et al.Journal of Medicinal Chemistry|January 8, 2025
Selective Mu-Opioid Receptor Imaging Using 18F-Labeled CarfentanilsSo Jeong Lee, Torben D Pearson, Maeva Dhaynaut, et al.Communications Biology|November 22, 2025
UDP-glucose and MRS2905 agonist-bound states of the purinergic P2Y14 receptorJonathan F Fay, Joseph Kousouros, Zhan-Guo Gao, et al.Molecular Pharmacology|July 3, 2009
Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessmentXi-Ping Huang, Vincent Setola, Prem N Yadav, et al.Biorxiv : the Preprint Server for Biology|May 10, 2023
De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep Learning FrameworkLeslie Salas-Estrada, Davide Provasi, Xing Qui, et al.Bioorganic & Medicinal Chemistry|May 8, 2014
Identification of a new selective dopamine D4 receptor ligandDinithia Sampson, Xue Y Zhu, Suresh V K Eyunni, et al.Journal of Medicinal Chemistry|April 10, 2019
D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on CariprazineYudao Shen, John D McCorvy, Michael L Martini, et al.Pageof 43